FR2825925A1 - Production of an active agent having a nutritional effect on the skin comprises enzymatic hydrolysis of vegetable, animal or marine proteins - Google Patents

Production of an active agent having a nutritional effect on the skin comprises enzymatic hydrolysis of vegetable, animal or marine proteins Download PDF

Info

Publication number
FR2825925A1
FR2825925A1 FR0108035A FR0108035A FR2825925A1 FR 2825925 A1 FR2825925 A1 FR 2825925A1 FR 0108035 A FR0108035 A FR 0108035A FR 0108035 A FR0108035 A FR 0108035A FR 2825925 A1 FR2825925 A1 FR 2825925A1
Authority
FR
France
Prior art keywords
daltons
active ingredient
molecular weight
animal
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0108035A
Other languages
French (fr)
Other versions
FR2825925B1 (en
Inventor
Jean Jacques Paufique
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle Limousine dApplication Biologique SA SILAB
Original Assignee
Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8864499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2825925(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe Industrielle Limousine dApplication Biologique SA SILAB filed Critical Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority to FR0108035A priority Critical patent/FR2825925B1/en
Priority to PCT/FR2002/002114 priority patent/WO2002102347A2/en
Publication of FR2825925A1 publication Critical patent/FR2825925A1/en
Application granted granted Critical
Publication of FR2825925B1 publication Critical patent/FR2825925B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a method for the extraction of an active component with a nutritional effect on the skin, characterised in comprising the following steps: solubilisation of animal, vegetable or fish proteins in water, with a proportion of at least 5 % by weight; simultaneous or successive hydrolysis of the above suspension in the presence of one or several enzymes chosen from bacterial aminopeptidases applicable in neutral or acid medium, animal stomach proteases applicable in an acid medium, bacterial proteases applicable in a neutral medium, bacterial proteases applicable in an alkaline medium extracted from Bacillus Licheniformis or Bacillus Subtilis, bacterial endoproteases or pancreatic enzymes of animal origin; concentration of the active fraction of small peptides of molecular mass less than 1400 daltons and a sterilising filtration to give a total mesophilic flora of less than 100 germs/g and an absence of yeasts and moulds. The invention also relates to obtained active component and the cosmetic compositions comprising the above.

Description

<Desc/Clms Page number 1> <Desc / Clms Page number 1>

PROCEDE DE PREPARATION D'UN PRINCIPE ACTIF A PARTIR DE RIZ,
PRINCIPE ACTIF OBTENU ET COMPOSITIONS ADAPTEES
La presente invention concerne un procède de preparation d'un prinCipe actif à partir de riz et le principe actif obtenu.
PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE,
ACTIVE PRINCIPLE OBTAINED AND ADAPTED COMPOSITIONS
The present invention relates to a process for the preparation of an active principle from rice and the active ingredient obtained.

L'invention couvre aussi des compositions utilisant un tel principe actif.  The invention also covers compositions using such an active ingredient.

Dans le cas de la peau, le principe actif selon la présente invention a pour but de présenter de fortes capacités d'assimilation par la peau afin de lui apporter rapidement des éléments nutritionnels. Ces éléments nutritionnels vont faciliter les fonctions métaboliques et permettre aux cellules de la peau soumises au stress, de récupérer rapidement.  In the case of the skin, the active principle according to the present invention aims to have strong assimilation capabilities through the skin to quickly provide nutritional elements. These nutritional elements will facilitate the metabolic functions and allow the cells of the skin subjected to stress, to recover quickly.

Pour cet effet, l'invention propose un principe actif à partir d'éléments à structure peptidique ayant un faible poids moléculaire.  For this purpose, the invention provides an active ingredient from peptide structure elements having a low molecular weight.

Les unités peptidiques purifiées ainsi apportées accélèrent l'assimilation cellulaire et vitalisent la peau.  The purified peptide units thus added accelerate cell assimilation and vitalize the skin.

Une peau ainsi nourrie, revitalisée permet notamment de lutter contre le vieillissement tissulaire donc de combler les rides.  A skin thus nourished, revitalized helps in particular to fight against the tissue aging thus to fill wrinkles.

On connaît un procédé de fabrication d'un hydrolysat de protéines riches en di-et tri-peptides pour la nutrition artificielle et utilisées en diététique.  There is known a process for producing a protein hydrolyzate rich in di- and tri-peptides for artificial nutrition and used in dietetics.

Ce procédé consiste à soumettre une protéine du blanc d'oeuf ou de la caséine, à l'action simultanée ou successive d'enzymes, en l'occurrence une protéase bactérienne utilisable en milieu neutre, une protéase bactérienne utilisable en milieu alcalin et une enzyme pancréatique d'origine animale.  This process consists in subjecting an egg white or casein protein to the simultaneous or successive action of enzymes, in this case a bacterial protease that can be used in a neutral medium, a bacterial protease that can be used in an alkaline medium, and an enzyme. pancreatic of animal origin.

<Desc/Clms Page number 2> <Desc / Clms Page number 2>

Dans la présente demande, il convient d'obtenir un hydrolysat de protéines avec une fraction à faible poids moléculaire pour être absorbée par la peau.  In the present application, it is necessary to obtain a protein hydrolyzate with a low molecular weight fraction to be absorbed by the skin.

Dans l'art antérieur, comme il s'agit d'alimentation artificielle, le poids moléculaire n'est pas une contrainte et les produits obtenus par ces procédés ne permettraient aucunement une application à la cosmétologie.  In the prior art, as it is artificial feeding, the molecular weight is not a constraint and the products obtained by these methods would not allow any application to cosmetology.

L'invention est maintenant décrite en détail, tant dans ses étapes du procédé d'obtention que dans la caractérisation du produit obtenu et à travers des compositions cosmétiques adaptées.  The invention is now described in detail, both in its steps of the method of obtaining that in the characterization of the product obtained and through suitable cosmetic compositions.

Les différentes figures représentent : - figure 1, une courbe de distribution des fractions peptidiques obtenues.  The various figures represent: FIG. 1, a distribution curve of the peptide fractions obtained.

- figure 2, tableau des résultats sur la prolifération de fibroblastes au cours du temps, - figure 3, tableau des résultats sur la prolifération de fibroblastes comparée à d'autres compositions, - figure 4, tableau des résultats de récupération cellulaire après un stress UV, - figure 5, tableau des résultats de l'activité stimulante du principe actif, - figures 6A et 6B, des tableaux de résultats de pression partielle d'oxygène et de dioxyde de carbone, - figures 7A et 7B, des tableaux de résultats d'analyses sur volontaires concernant l'oxygénation tissulaire, et - figure 8, tableau récapitulant les améliorations vis-à-vis des rides.  FIG. 2, table of results on the proliferation of fibroblasts over time, FIG. 3, table of results on the proliferation of fibroblasts compared to other compositions, FIG. 4, table of the results of cellular recovery after a UV stress. FIG. 5, table of the results of the stimulating activity of the active principle, FIGS. 6A and 6B, tables of oxygen partial pressure results and carbon dioxide, FIGS. 7A and 7B, tables of results of analyzes on volunteers concerning tissue oxygenation, and - figure 8, table summarizing the improvements with respect to wrinkles.

1/PROCEDE D'EXTRACTION D'UN PRINCIPE ACTIF A PARTIR DE RIZ
Le produit selon l'invention dont on souhaite obtenir un concentrat constituant le principe actif selon l'invention, est du riz, notamment la variété
Orysa Sativa. Le procédé consiste à réaliser la succession des étapes suivantes : - solubilisation d'un concentré de protéines de riz dans l'eau, notamment la variété Orysa Sativa, à raison d'au moins 5% en poids.
1 / PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM RICE
The product according to the invention, of which it is desired to obtain a concentrate constituting the active ingredient according to the invention, is rice, in particular the variety
Orysa Sativa. The method consists in carrying out the following succession of steps: solubilization of a rice protein concentrate in water, in particular the Orysa Sativa variety, in a proportion of at least 5% by weight.

<Desc/Clms Page number 3> <Desc / Clms Page number 3>

- hydrolyses successives de cette suspension en présence d'une- protéase stomacale d'origine animale utilisable en milieu acide, - concentration de la fraction active en petits peptides de masse moléculaire inférieure à 1 400 daltons, - filtration stérilisante pour atteindre une flore mésophile totale inférieure à 100 germes/g, et une absence de levures et de moisissures.  successive hydrolyses of this suspension in the presence of a stomach protease of animal origin that can be used in an acid medium; concentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons; sterilizing filtration to reach a total mesophilic flora less than 100 germs / g, and an absence of yeasts and molds.

On réalise une courbe représentée sur la figure 1 sur une colonne commercialisée sous la dénomination Superdex Peptide. On utilise une solution tampon phosphate 0,02 mole additionnée de 0,25 mole NaCI et on travaille à pH 7,2.  A curve is shown in FIG. 1 on a column sold under the name Superdex Peptide. A 0.02 mol phosphate buffer solution containing 0.25 mol of NaCl is used and the pH is adjusted to 7.2.

Le débit sur la colonne est de 0,25 ml/mn et se traduit sur papier par 0,25 cm/mn.  The flow rate on the column is 0.25 ml / min and is printed on paper at 0.25 cm / min.

On constate que la fraction inférieure à 1355 daltons est répartie de la façon suivante :

Figure img00030001

- f3 : 32, 63% (1400 < masse moléculaire < 175), soit environ 33, 00% - f4 : 42, 01 % (175 < masse moléculaire < 75), soit environ 42, 00% et - f5 : 2, 61 % (masse moléculaire < 75), soit environ 3%, c'est-à-dire les peptides de faibles masses moléculaires, représentent 77, 25% ou au moins 3/4 de la fraction totale inférieure à 1400 daltons. It can be seen that the fraction below 1355 daltons is distributed as follows:
Figure img00030001

- 32: 63% (1400 <molecular weight <175), ie about 33.00% - f4: 42.01% (175 <molecular weight <75), ie about 42.00% and -f5: 2, 61% (molecular weight <75), ie about 3%, i.e. the peptides of low molecular weight, represent 77, 25% or at least 3/4 of the total fraction less than 1400 daltons.

22, 5% sont supérieurs à 1400 daltons
Cette structure peptidique du principe actif selon l'invention est spécifique et de faible masse moléculaire, permettant ainsi les applications à la cosmétique comme le montrent les résultats qui vont suivre.
22, 5% are greater than 1400 daltons
This peptide structure of the active ingredient according to the invention is specific and of low molecular weight, thus allowing applications to cosmetics as shown by the results that follow.

2/CARACTERISATION DU PRINCIPE ACTIF OBTENU
Taux de matière sèche :
Le taux de matière sèche est obtenu par passage du principe actif

Figure img00030002

extrait dans une étuve à 105 C jusqu'à obtention d'un poids constant. La quantité de matière sèche obtenue est comprise entre 20 et 150 g/l, plus particulièrement comprise entre 50 et 80 g/t. 2 / CHARACTERIZATION OF THE ACTIVE PRINCIPLE OBTAINED
Dry matter content:
The dry matter content is obtained by passage of the active ingredient
Figure img00030002

extracted in an oven at 105 C until a constant weight. The quantity of dry matter obtained is between 20 and 150 g / l, more particularly between 50 and 80 g / t.

<Desc/Clms Page number 4> <Desc / Clms Page number 4>

Mesure du pH :
Le pH est mesuré par la méthode potentiométrique à température ambiante. Le pH est compris entre 4,0 et 10, plus particulièrement entre 5,0 et 7,0.
PH measurement:
The pH is measured by the potentiometric method at room temperature. The pH is between 4.0 and 10, more preferably between 5.0 and 7.0.

Détermination de la teneur en azote :
La détermination est réalisée par la méthode de Kjeldhal.
Determination of the nitrogen content:
The determination is carried out by Kjeldhal's method.

La teneur en protéines déduite est comprise entre 10 et 100 g/ ! et plus particulièrement entre 40 et 60 girl.  The deduced protein content is between 10 and 100 g /! and more particularly between 40 and 60 girl.

3/EFFETS DU PRINCIPE ACTIF SUR LA PROLIFERATION DE FIBROBLASTES HUMAINS
3-1 Effets au cours du temps :
L'étude est conduite sur des fibroblastes humains auxquels on ajoute le principe actif selon l'invention à 1 % et 2% en volume.
3 / EFFECTS OF THE ACTIVE INGREDIENT ON THE PROLIFERATION OF HUMAN FIBROBLASTS
3-1 Effects over time:
The study is conducted on human fibroblasts to which the active ingredient according to the invention is added at 1% and 2% by volume.

Après 48 et 72 heures supplémentaires, on mesure le pourcentage de prolifération.  After 48 and 72 additional hours, the percentage of proliferation is measured.

Les résultats sont consignés dans le tableau de la figure 2.  The results are shown in the table in Figure 2.

Le principe actif augmente fortement la prolifération des cellules, de façon dose dépendante, plus particulièrement après 72 heures de traitement.  The active ingredient greatly increases the proliferation of cells, in a dose-dependent manner, more particularly after 72 hours of treatment.

3-2 Influence de la structure chimique
Le but est d'étudier l'influence de la structure biochimique du principe actif selon la présente invention sur le métabolisme de fibroblastes humains en culture.
3-2 Influence of the chemical structure
The aim is to study the influence of the biochemical structure of the active ingredient according to the present invention on the metabolism of human fibroblasts in culture.

A cet effet, on compare les effets de quatre compositions sur la prolifération après 72 heures de traitement : - principe actif selon la présente invention avec 77% de peptides de masse moléculaire < 1 400 daltons.  For this purpose, the effects of four compositions on proliferation are compared after 72 hours of treatment: active ingredient according to the present invention with 77% of peptides with a molecular mass <1400 daltons.

- mélange modèle d'acides aminés, ceux-ci n'étant pas structurés en petits peptides, - solution de protéines hautement structurées, et  - model amino acid mixture, these being not structured in small peptides, - solution of highly structured proteins, and

<Desc/Clms Page number 5><Desc / Clms Page number 5>

- solution de peptides de riz non sélectionnés avec seulement 37% de masse moléculaire inférieure à 1400 daltons.  - solution of unselected rice peptides with only 37% molecular weight less than 1400 daltons.

On constate à travers les résultats du tableau de la figure 3, que le principe actif selon la présente invention augmente considérablement la prolifération des fibroblastes. Sa structure peptidique optimale est adaptée à la prolifération cellulaire.  It can be seen from the results of the table of FIG. 3 that the active principle according to the present invention considerably increases the proliferation of fibroblasts. Its optimal peptide structure is adapted to cell proliferation.

Le mélange modèle d'acides aminés ne modifie pas la capacité de prolifération, ce qui montre que ce n'est pas la composition en acides aminés du principe actif qui procure à ce principe actif sa capacité à favoriser la prolifération.  The model amino acid mixture does not modify the proliferation capacity, which shows that it is not the amino acid composition of the active ingredient that gives this active ingredient its ability to promote proliferation.

Les protéines hautement structurées ne modifient pas non plus la capacité de prolifération et elles ne sont pas assimilées. Les cellules doivent consommer de l'énergie lors d'une hydrolyse préalable afin d'utiliser cette source protéique.  Highly structured proteins also do not alter the proliferation capacity and they are not assimilated. The cells must consume energy during a prior hydrolysis to use this protein source.

Les peptides de riz non sélectionnés ne permettent pas d'améliorer l'activité prolifératrice des cellules autant que le principe actif.  The unselected rice peptides do not make it possible to improve the proliferative activity of the cells as much as the active principle.

4/EFFET DU PRINCIPE ACTIF A COMPENSER LES EFFETS D'UN STRESS SOLAIRE
Cette étude a pour but de démontrer que le principe actif selon l'invention favorise la récupération après un stress, par exemple un stress solaire.
4 / EFFECT OF THE ACTIVE PRINCIPLE TO COMPENSATE THE EFFECTS OF A SOLAR STRESS
This study aims to demonstrate that the active ingredient according to the invention promotes recovery after stress, for example solar stress.

Pour ce test, on mesure la viabilité cellulaire des fibroblastes humains soumis à des irradiations UVA et UVB, en présence ou non de principe actif selon la présente invention après 48 ou 72 heures.  For this test, the cell viability of human fibroblasts subjected to UVA and UVB irradiations, in the presence or absence of active principle according to the present invention after 48 or 72 hours, is measured.

Les doses sont de 6 joules/cm2 en UVA et de 0,48 joules/cm2 en UVB et les résultats sont exprimés en densité optique à 540 nm.  The doses are 6 joules / cm 2 in UVA and 0.48 joules / cm 2 in UVB and the results are expressed in optical density at 540 nm.

On constate dans le tableau de la figure 4 que le stress solaire induit une forte toxicité et provoque la mort de 60% des fibroblastes. Le principe actif à 1 % permet d'augmenter de 35% le nombre de cellules en activant les fonctions métaboliques des cellules.  It can be seen in the table in FIG. 4 that solar stress induces a high toxicity and causes the death of 60% of the fibroblasts. The active ingredient at 1% makes it possible to increase the number of cells by 35% by activating the metabolic functions of the cells.

<Desc/Clms Page number 6> <Desc / Clms Page number 6>

5/EFFET DU PRINCIPE ACTIF SUR L'EXPRESSION DES ARNm
Le principe actif selon la présente invention a une action sur les ARN messagers codant pour les collagènes VII et t) t et) a fibronectine en milieu nutritif carencé.
5 / EFFECT OF THE ACTIVE INGREDIENT ON mRNA EXPRESSION
The active ingredient according to the present invention has an action on messenger RNAs encoding collagen VII and t) and fibronectin in a nutrient-deficient medium.

En effet, des fibroblastes humains sont incubés dans un milieu complet et dans un milieu nutritif carencé, en présence du principe actif.  Indeed, human fibroblasts are incubated in complete medium and in a nutrient deficient medium, in the presence of the active ingredient.

Les résultats obtenus sont exprimés en pourcentage d'expression de l'ARNm de la protéine étudiée par rapport à un témoin.  The results obtained are expressed as a percentage of expression of the mRNA of the studied protein relative to a control.

Ils font l'objet du tableau de la figure 5.  They are shown in the table in Figure 5.

Le principe actif augmente de façon significative l'expression des ARNm codant pour les coilagènes lil, Vll et la fibronectine donc des protéines constitutives du derme. Le principe actif permet de maintenir l'équilibre indispensable à la diététique cellulaire.  The active ingredient significantly increases the expression of the mRNAs encoding the collagens lil, VII and fibronectin therefore constitutive proteins of the dermis. The active ingredient helps maintain the balance necessary for cellular dietetics.

6/EFFET DU PRINCIPE ACTIF SUR LE METABOLISM PAR MESURE DE SYNTHESE D'ATP
Cette étude permet d'évaluer l'activité stimulante du principe actif selon la présente invention sur le stock d'adénosinetriphosphate intracellulaire
On applique sur plusieurs épidermes une formulation de principe actif à 4% selon la présente invention, après 24 heures de contact, on dose l'ATP par luminométrie à l'aide d'un test du commerce.
6 / EFFECT OF THE ACTIVE INGREDIENT ON METABOLISM BY ATP SYNTHESIS MEASUREMENT
This study makes it possible to evaluate the stimulating activity of the active ingredient according to the present invention on the intracellular adenosinetriphosphate stock.
A formulation of active ingredient at 4% according to the present invention is applied to several epidermides. After 24 hours of contact, ATP is assayed by luminometry using a commercial test.

On remarque dans le tableau de la figure 6 que les réserves d'ATP intracellulaire sont diminuées de 37% pour orienter l'énergie vers la synthèse cellulaire, augmentant ainsi les capacités de défense de la peau.  Note in the table of Figure 6 that the reserves of intracellular ATP are decreased by 37% to direct the energy towards cell synthesis, thus increasing the defense capabilities of the skin.

7/EFFET DU PRINCIPE ACTIF SUR L'OXYGENATION TISSULAIRE
L'objectif de cette étude est de quantifier, in vivo, sur l'homme, l'effet oxygénant du principe actif.
7 / EFFECT OF THE ACTIVE INGREDIENT ON TISSUE OXYGENATION
The objective of this study is to quantify, in vivo, on the man, the oxygenating effect of the active principle.

A cet effet, on mesure les pressions partielles d'oxygène et de dioxyde de carbone transcutanées sur une zone traitée avec une formulation à 4% de principe actif contre placebo.  For this purpose, the partial pressures of oxygen and carbon dioxide transcutaneous on a treated area with a formulation containing 4% of active ingredient against placebo.

<Desc/Clms Page number 7> <Desc / Clms Page number 7>

Les mesures sont réalisées avant et après 28 jours d'applications bi-- quotidiennes du principe actif.  The measurements are carried out before and after 28 days of bi-daily application of the active ingredient.

Les mesures de pression partielle sont effectuées de façon connue pour l'oxygène par mesure des variations de microcourants électriques et pour le dioxyde de carbone par détermination du pH d'un électrolyte également par mesure des variations de microcourants électriques. Les variations du pH sont proportionnelles au logarithme des variations de la pression partielle en dioxyde de carbone.  The partial pressure measurements are carried out in a known manner for oxygen by measuring the variations of electrical microcurrent and for carbon dioxide by determining the pH of an electrolyte also by measuring the variations of electrical microcurrent. The pH changes are proportional to the logarithm of carbon dioxide partial pressure changes.

Les mesures sont exprimées en mm de mercure.  The measurements are expressed in mm of mercury.

Les tableaux des figures 7A et 7B regroupent les résultats et font apparaître une augmentation de la pression partielle d'oxygène chez 54% des volontaires et de la pression partielle de C02 chez 61 % des volontaires.  The tables of FIGS. 7A and 7B combine the results and show an increase in the partial pressure of oxygen in 54% of the volunteers and in the partial pressure of CO 2 in 61% of the volunteers.

Ainsi, on constate que le principe actif tend à permettre une meilleure diffusion de l'oxygène dans les cellules et les tissus.  Thus, it is found that the active ingredient tends to allow a better diffusion of oxygen in cells and tissues.

81 EFFET ANTI-RIDES DU PRINCIPE ACTIF
Le but de l'étude est de vérifier sur 20 volontaires l'efficacité anti-rides du principe actif formulé à 5% contre placebo, appliqué biquotidiennement pendant deux mois.
81 ANTI-WRINKLE EFFECT OF THE ACTIVE INGREDIENT
The purpose of the study is to check on 20 volunteers the anti-wrinkle efficacy of the active ingredient formulated at 5% against placebo, applied twice daily for two months.

L'étude anti-rides consiste à analyser par observation des empreintes des pattes d'oie, à l'aide d'un profilomètre muni d'un analyseur d'images.  The anti-wrinkle study consists of analyzing the footprints of the crow's feet using a profilometer equipped with an image analyzer.

Les quatre paramètres étudiés sont : - surface totale ridée, - longueur des rides, - profondeur des rides, et - nombre de rides.  The four parameters studied are: - total wrinkled surface, - length of wrinkles, - depth of wrinkles, and - number of wrinkles.

Les résultats sont regroupés dans le tableau de la figure 8.  The results are summarized in the table of Figure 8.

L'analyse montre une forte diminution de 32% de la surface totale ridée et de 24% de la longueur des rides et la distribution confirme que cette diminution intéresse 70% des volontaires.  The analysis shows a sharp decrease of 32% of the wrinkled total area and 24% of the length of the wrinkles and the distribution confirms that this decrease concerns 70% of the volunteers.

<Desc/Clms Page number 8> <Desc / Clms Page number 8>

L'invention couvre aussi la composition cosmétique obtenue.  The invention also covers the cosmetic composition obtained.

Cette composition cosmétique nutritionnelle à fortes capacités d'assimilation comprend 0,10% à 5,00% de principe actif selon l'invention, associé (s) à des excipients et sous une forme galénique adaptée tel que : crème, gel, onguent, lotion, lait, émulsion ou solution. This nutritional cosmetic composition with high assimilative capacity comprises 0.10% to 5.00% of active ingredient according to the invention, combined with excipients and in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution.

Claims (5)

REVENDICATIONS 1. Procédé d'extraction d'un principe actif ayant une action nutritionnelle de la peau, caractérisé en ce qu'il comprend la succession des étapes suivantes : - solubilisation d'un concentré de protéines de riz dans l'eau, notamment la variété Orysa Sativa, à raison d'au moins 5% en poids, - hydrolyses successives de cette suspension en présence d'une protéase stomacale d'origine animale, utilisable en milieu acide, - concentration de la fraction active en petits peptides de masse moléculaire inférieure à 1 400 daltons, - filtration stérilisante pour atteindre une flore mésophile totale inférieure à 100 germes/g, et une absence de levures et de moisissures. 1. A method for extracting an active ingredient having a nutritional action of the skin, characterized in that it comprises the following succession of steps: - solubilization of a rice protein concentrate in water, especially the variety Orysa Sativa, at least 5% by weight, - successive hydrolysis of this suspension in the presence of a stomach protease of animal origin, usable in an acidic medium, - concentration of the active fraction in small peptides of lower molecular mass at 1400 daltons, - sterilizing filtration to achieve total mesophilic flora less than 100 germs / g, and an absence of yeasts and molds. 2. Principe actif obtenu par le procédé selon la revendication 1, caractérisé en ce qu'il présente : - une faible masse moléculaire inférieure à 1 400 daltons - un taux de matière sèche compris entre 20 et 150 g/t - un pH compris entre 4,0 et 10,0 et - une teneur en protéines comprise entre 10 et 100 g/t  2. Active ingredient obtained by the process according to claim 1, characterized in that it has: - a low molecular weight of less than 1400 daltons - a dry matter content of between 20 and 150 g / t - a pH between 4.0 and 10.0 and - a protein content of between 10 and 100 g / t 3. Principe actif selon la revendication 2, caractérisé en ce que la masse moléculaire est répartie de la façon suivante : - 22, 50% ayant une masse molaire supérieure à 1400 daltons, - 33, 00% ayant une masse moléculaire comprise entre 1400 et 175 daltons, - 42, 00% 175 et 75 daltons et - 3, 00% ayant une masse moléculaire inférieure 75 daltons. 3. Active ingredient according to claim 2, characterized in that the molecular weight is distributed as follows: 22.50% having a molar mass greater than 1400 daltons, 33.00% having a molecular weight between 1400 and 175 daltons, 42.00% 175 and 75 daltons and -3.00% having a molecular weight of less than 75 daltons. 4. Principe actif selon la revendication 2 ou 3, caractérisé en ce qu'il présente : - un taux de matière sèche est compris entre 50,0 et 80,0 g/l, - un pH compris entre 5,0 et 7,0 et - une teneur en protéine est comprise entre 40,0 et 60,0 g/t.  4. Active ingredient according to claim 2 or 3, characterized in that it has: - a solids content is between 50.0 and 80.0 g / l, - a pH between 5.0 and 7, And a protein content is between 40.0 and 60.0 g / t. <Desc/Clms Page number 10> <Desc / Clms Page number 10> 5. Composition cosmétique nutritionnelle à fortes capacités d'assimilation, caractérisée en ce qu'elle comprend 0,10% à 5,00% de principe actif selon l'une des revendications 2,3 ou 4 associé (s) à des excipients et sous une forme galénique adaptée tel que : crème, gel, onguent, lotion, lait, émulsion ou solution. 5. Nutritional cosmetic composition with high assimilative capacity, characterized in that it comprises 0.10% to 5.00% of active principle according to one of claims 2, 3 or 4 associated with excipients and in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution.
FR0108035A 2001-06-19 2001-06-19 PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS Expired - Lifetime FR2825925B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0108035A FR2825925B1 (en) 2001-06-19 2001-06-19 PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS
PCT/FR2002/002114 WO2002102347A2 (en) 2001-06-19 2002-06-19 Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108035A FR2825925B1 (en) 2001-06-19 2001-06-19 PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS

Publications (2)

Publication Number Publication Date
FR2825925A1 true FR2825925A1 (en) 2002-12-20
FR2825925B1 FR2825925B1 (en) 2005-01-28

Family

ID=8864499

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108035A Expired - Lifetime FR2825925B1 (en) 2001-06-19 2001-06-19 PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS

Country Status (2)

Country Link
FR (1) FR2825925B1 (en)
WO (1) WO2002102347A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007065718A1 (en) * 2005-12-08 2007-06-14 Dsm Ip Assets B.V. Protective hydrocolloid for active ingredients
WO2007077318A2 (en) * 2005-12-22 2007-07-12 Societe D'extraction Des Pricipes Actifs Sa (Vincience) Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
FR2899105A1 (en) * 2006-03-30 2007-10-05 Soc Extraction Principes Actif Cosmetic/dermatological/pharmaceutical composition, with immunostimulant activity on skin, useful e.g. to protect/strengthen Langerhans cells and cutaneous immune defense system, comprises hydrolyzate of Poaceae family plant protein
WO2008015341A2 (en) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2906719A1 (en) * 2006-10-05 2008-04-11 Limousine D Applic Biolog Dite USE OF SUBSTANCES ACTING ON PAPILLARY DERMAS FOR ANTI-AGING ACTION.
FR2915379A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate aconitase and protect mitochondria
FR2915383A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to increase cellular energy and protect skin from oxidative damage
FR2915380A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate cytochrome and protect mitochondrion
FR2945444A1 (en) * 2009-05-13 2010-11-19 Limousine D Applic Biolog Dite Use of an agent increasing expression of nicotinic acetylcholine receptor of skin cells, as an active ingredient for preparing a cosmetic composition for improving and/or repairing the skin barrier function
FR2975298A1 (en) * 2011-05-16 2012-11-23 Silab Sa Use of peptides from Cynara scolymus leaves, or a hydrolyzate of Cynara scolymus leaves comprising peptides, in a cosmetic composition, which is useful for treating aging of the skin

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175501B1 (en) 2002-12-02 2004-11-15 Green Earth Plant and process for continuous hydrolysis of a proteinaceous animal or vegetable feedstock
WO2008115165A2 (en) * 2004-04-20 2008-09-25 Mgp Ingredients, Inc. Method of hydrolyzing rice protein concentrate with protease enzymes
FR2874503B1 (en) 2004-09-01 2006-11-24 Soc Ind Limousine Dapplication Biologique Silab PROCESS FOR OBTAINING AN ACTIVE ACTIVE FIRMING AND ANTI-STRETCHING ACTIVE INGREDIENT AND THE FUNCTIONALITIES
FR2877568B1 (en) 2004-11-10 2008-03-21 Oreal COSMETIC COMPOSITION COMPRISING RICE PROTEIN HYDROLYSAT AND AGENT INCREASING GLYCOSAMINOGLYCAN SYNTHESIS
FR2903903B1 (en) 2006-07-18 2008-08-29 Expanscience Laboratoires Sa USE OF A RICE PROTEIN HYDROLYZATE AS A PIGMENTANT ACTIVE INGREDIENT
DE102007052536A1 (en) 2007-11-01 2009-05-07 Beiersdorf Ag Active substance combinations of aniseed fruit extract and white tea extract
DE102007062691A1 (en) 2007-12-21 2009-06-25 Beiersdorf Ag Drug combinations of aniseed extract and one or more 2,3-Dibenzylbutyrolactonen
DE102008034265A1 (en) 2008-07-22 2010-01-28 Beiersdorf Ag Active substance combination of aniseed extract and hyaluronic acid
FR2958847B1 (en) * 2010-04-15 2013-06-28 Isp Investments Inc USE OF PEPTIDE PEPTIDE HYDROLYZATE AS ACTIVE MOISTURIZING AGENT
JP2012067042A (en) * 2010-09-24 2012-04-05 Oriza Yuka Kk Collagen production promoter and collagen gene expression promoter
EP2514403A1 (en) * 2011-04-20 2012-10-24 Coty Germany GmbH Cosmetic composition for increasing the collagen synthesis in the skin cells
DE102012211807A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and hyaluronic acid and their cosmetic and / or dermatological use
DE102012211797A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and aniseed extract and their cosmetic and / or dermatological use
DE102012219884A1 (en) 2012-10-31 2014-04-30 Beiersdorf Ag Aqueous cosmetic/dermatological composition, used to treat skin aging and to treat, care and clean skin, comprises aqueous anise fruit extract, substances with specified hydrophilic-lipophilic balance value, and polyethylene glycol-8
CN117229355B (en) * 2023-09-26 2024-09-17 华南农业大学 Active peptide derived from pumpkin seed cake, and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117129A (en) * 1991-10-24 1993-05-14 Kurooda Japan Kk Skin external agent
JPH05221844A (en) * 1992-02-17 1993-08-31 Kyoei Kagaku Kogyo Kk Aging-preventive cosmetic
DE19502167A1 (en) * 1995-01-25 1996-08-01 Henkel Kgaa Process for the production of rice protein hydrolyzates
WO1997006780A1 (en) * 1995-08-18 1997-02-27 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations containing acyl lactylates, protein hydrolysates and protein fatty acid condensates
JPH0987133A (en) * 1995-09-21 1997-03-31 Techno-Bull:Kk Cosmetic capable of preventing aging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223528B (en) * 1987-12-18 1990-09-19 Eniricerche Spa USE OF AN ENZYMATIC SYSTEM OF VEGETAL ORIGIN IN THE ENZYMATIC HYDROLYSIS OF PROTEIN MATERIAL AND PRODUCTS SO OBTAINED

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117129A (en) * 1991-10-24 1993-05-14 Kurooda Japan Kk Skin external agent
JPH05221844A (en) * 1992-02-17 1993-08-31 Kyoei Kagaku Kogyo Kk Aging-preventive cosmetic
DE19502167A1 (en) * 1995-01-25 1996-08-01 Henkel Kgaa Process for the production of rice protein hydrolyzates
WO1997006780A1 (en) * 1995-08-18 1997-02-27 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations containing acyl lactylates, protein hydrolysates and protein fatty acid condensates
JPH0987133A (en) * 1995-09-21 1997-03-31 Techno-Bull:Kk Cosmetic capable of preventing aging

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMICAL ABSTRACTS [online] XP002197954, Database accession no. 1993:678371 *
DATABASE WPI Week 199723, Derwent World Patents Index; AN 1997-255414, XP002197955 *
PATENT ABSTRACTS OF JAPAN vol. 17, no. 475 (C - 1103) *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133254B2 (en) 2005-12-08 2015-09-15 Dsm Ip Assets B.V. Protective, hydrocolloid for active ingredients
WO2007065718A1 (en) * 2005-12-08 2007-06-14 Dsm Ip Assets B.V. Protective hydrocolloid for active ingredients
WO2007077318A2 (en) * 2005-12-22 2007-07-12 Societe D'extraction Des Pricipes Actifs Sa (Vincience) Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
WO2007077318A3 (en) * 2005-12-22 2007-10-11 Extraction Des Pricipes Actifs Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
FR2899105A1 (en) * 2006-03-30 2007-10-05 Soc Extraction Principes Actif Cosmetic/dermatological/pharmaceutical composition, with immunostimulant activity on skin, useful e.g. to protect/strengthen Langerhans cells and cutaneous immune defense system, comprises hydrolyzate of Poaceae family plant protein
WO2008015341A2 (en) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
WO2008015341A3 (en) * 2006-08-03 2008-04-10 Soc Extraction Principes Actif Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2906719A1 (en) * 2006-10-05 2008-04-11 Limousine D Applic Biolog Dite USE OF SUBSTANCES ACTING ON PAPILLARY DERMAS FOR ANTI-AGING ACTION.
FR2915383A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to increase cellular energy and protect skin from oxidative damage
FR2915380A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate cytochrome and protect mitochondrion
FR2915379A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate aconitase and protect mitochondria
FR2945444A1 (en) * 2009-05-13 2010-11-19 Limousine D Applic Biolog Dite Use of an agent increasing expression of nicotinic acetylcholine receptor of skin cells, as an active ingredient for preparing a cosmetic composition for improving and/or repairing the skin barrier function
FR2975298A1 (en) * 2011-05-16 2012-11-23 Silab Sa Use of peptides from Cynara scolymus leaves, or a hydrolyzate of Cynara scolymus leaves comprising peptides, in a cosmetic composition, which is useful for treating aging of the skin

Also Published As

Publication number Publication date
WO2002102347A3 (en) 2003-12-04
WO2002102347A2 (en) 2002-12-27
FR2825925B1 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
FR2825925A1 (en) Production of an active agent having a nutritional effect on the skin comprises enzymatic hydrolysis of vegetable, animal or marine proteins
Kang et al. Characterization of growth and protein contents from microalgae Navicula incerta with the investigation of antioxidant activity of enzymatic hydrolysates
JP4854199B2 (en) Functional material obtained by re-fermenting liquefied sake lees
Ryu et al. Statistical optimization of microalgae Pavlova lutheri cultivation conditions and its fermentation conditions by yeast, Candida rugopelliculosa
TWI757293B (en) Bacterial cell, cell culture or extract of Yarrowia lipolytica containing L-hydroxyproline, use thereof, and method for producing L-hydroxyproline
WO2014061728A1 (en) Cosmetic composition
WO2017093345A1 (en) Method for culturing unicellular red algae (ura) with milk permeate
Rabie et al. Acceleration of mackerel fish sauce fermentation via bromelain addition
RU2529956C2 (en) Probiotic microorganisms, enriched with organic selenium based on compounds of selenium hydroxyacids, and their application in nutrition, cosmetics and pharmacy
Kolpakova et al. Pea and chickpea protein concentrates: quality indicators.
CN116606765A (en) Corn protein ferment, preparation method and application thereof
EP0850044B1 (en) Process for obtaining amino acids from proteins and use of the amino-acid-containing products obtained
FR3072031B1 (en) ACTIVE COSMETIC PRINCIPLE BASED ON GERMINED SEED EXTRACTS
CN107619070A (en) Reduce the additive that heavy metal seawater damages to big oyster active oxygen radical
Herawati et al. The effect of fermentation time with probiotic bacteria on organic fertilizer as Daphnia magna cultured medium towards nutrient quality, biomass production and growth performance enhancement
FR2796839A1 (en) USE OF A PROTEIN FRACTION OF THE SEED OF THE VIGNA TRILOBATA PLANT IN A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION
FR3024660A1 (en) NUTRIENT COMPLEX FOR PRODUCING A NUTRIENT COSMETIC COMPOSITION BASED ON MARINE SOURCE WATER AND ALGAE EXTRACT.
CN113980832B (en) Strain for efficiently degrading keratin and application thereof
Schmitz et al. Carrier-mediated uptake of L-leucine by the brown alga Giffordia mitchellae
KR102626239B1 (en) A cosmetic composition containing a sea urchin roe hydrolyzate or a sea urchin roe hydrolyzed fermented product, which has a function of improving wrinkles and regenerating skin, and a method for producing the same
CN110292538B (en) Composition and application thereof in preparation of whitening and anti-aging cosmetics
CN117987499B (en) Polypeptide composition, preparation method and application thereof, and daily chemical product
Chaveesuk Accleration of fish sauce fermentation using proteolytic enzymes
US20240197616A1 (en) Cosmetic composition comprising chlorella protothecoides extract for skin whitening or wrinkle improvement and preparation method therefor
Pawlikowska et al. Lysates of Metschnikowia yeast with higher content of hydroxyproline

Legal Events

Date Code Title Description
CJ Change in legal form
CJ Change in legal form

Effective date: 20120106

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 20